GLP-1 drug market large despite mood concerns.
The market for GLP-1 drugs remains large despite anecdotal concerns about mood side effects, as clinical data shows most patients' mood improves with obesity treatment, and issues like suicidality are not increased, supporting continued growth and adoption.
XBI
HIGH
CNBC
Apr 17, 16:53